Welcome!

News Feed Item

Precision Optics Corporation, Inc. Announces Operating Results for the Second Quarter and Six Months Ended December 31, 2013

GARDNER, MA -- (Marketwired) -- 02/18/14 -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") today announced operating results on an unaudited basis for the second quarter and six months ended December 31, 2013.

Highlights include:

  • Quarter-over-quarter sequential sales increase of 11.1%
  • Quarterly year-over-year sales increase of 102.1%
  • Reduction of year-over-year quarterly and year-to-date operating loss
  • Reduction of year-over-year cash used in operating activities

"The results of the quarter and six months ended December 31, 2013 continue to reflect significant and ongoing increases in our revenues. These revenue increases have been generated by an increase in the number and size of new projects that incorporate our Company's unique technology and capabilities," said Joseph Forkey, Precision Optics' Chief Executive Officer. "We are not only receiving new business from additional work with our current and existing customers, but we have been engaged by new medical device customers who are now beginning to recognize the potential of our proprietary technologies. While our gross margin percentage decreased during the last two quarters due to start-up costs associated with our new product introductions, we expect improvement in our gross margins as manufacturing procedures for these new products become more mature.

"We are particularly excited by recent progress on our next generation endoscope camera that utilizes a state-of-the art CMOS image sensor coupled with optics based on our Company's proprietary Microprecision™ lens technology. This endoscope represents the first of a new class of endoscopes that are able to achieve low per unit costs while still providing high quality, medical grade imaging. Satisfying both of these requirements simultaneously opens the medical device market to applications for single-use endoscopes, removing the requirement for re-sterilization and virtually eliminating the risk of cross-contamination from patient to patient."

The following table summarizes the second quarter and six months results for the periods ended December 31, 2013 and 2012 (unaudited):


                               Three Months               Six Months
                            Ended December 31,        Ended December 31,
                         ------------------------  ------------------------
                             2013         2012         2013         2012
                         -----------  -----------  -----------  -----------
Revenues                 $ 1,007,717  $   498,667  $ 1,915,143  $ 1,062,065

Gross Profit                 205,416       80,338      465,650      209,811

Operating Expenses           457,869      433,813      928,824      920,130

Operating Loss              (252,453)    (353,475)    (463,174)    (710,319)

Net Loss                    (252,453)    (906,484)    (463,174)  (1,264,578)

Loss Per Share:
  Basic                  $     (0.06) $     (0.22) $     (0.10) $     (0.47)
                         ===========  ===========  ===========  ===========
  Diluted                $     (0.06) $     (0.22) $     (0.10) $     (0.47)
                         ===========  ===========  ===========  ===========

Weighted Average Common
 Shares Outstanding:
  Basic                    4,455,134    4,035,656    4,455,134    2,688,788
                         ===========  ===========  ===========  ===========
  Diluted                  4,455,134    4,035,656    4,455,134    2,688,788
                         ===========  ===========  ===========  ===========

Revenues for the quarter ended December 31, 2013 were $1,007,717, as compared to $498,667 for the same period in the prior year, and represented an increase of 102.1%. Revenues for the quarter ended December 31, 2013 also represented a quarter-over-quarter sequential increase of 11.1% as compared to revenues of $907,426 for the quarter ending September 30, 2013. Revenues for the six months ended December 31, 2013 were $1,915,143, as compared to $1,062,065 for the same period in the prior year, and represented an increase of 80.3%.

The increase in revenues for the quarter and six months ended December 31, 2013 resulted from increases in the Company's ongoing sales of previously developed products, as well as sales of newly designed products, most of which are used for medical applications.

Operating loss for the quarter ended December 31, 2013 was $252,453, as compared to $353,475 for the same period in the prior year, and represented an improvement of $101,022. Operating loss for the six months ended December 31, 2013 was $463,174, as compared to $710,319 for the same period in the prior year, and represented an improvement of $247,145.

The decrease in the operating loss for the quarter and six months ended December 31, 2013 as compared to the same periods in the prior year is primarily attributed to lower research and development expenses incurred by the Company, along with higher reported sales and gross profit, partially offset by higher selling, consulting, legal and stock-based compensation expenses incurred.

Net loss for the quarter ended December 31, 2013 was $252,453, as compared to a net loss of $906,484 for the quarter ended December 31, 2012, and represented an improvement of $654,031.

Net loss for the six months ended December 31, 2013 was $463,174, as compared to a net loss of $1,264,578 for the six months ended December 31, 2012. Net loss in the quarter and six months ended December 31, 2012 included a non-cash expense for settlement of claims for liquidated damages of $629,000 and a non-cash gain on settlement of accounts payable of $76,149.

Cash and cash equivalents were $577,588 at December 31, 2013, as compared to $1,034,587 at June 30, 2013, and represented a decrease in cash of $456,999. Working capital (current assets minus current liabilities) at December 31, 2013 was $1,287,034, and represented a decrease of $391,107 as compared to working capital at June 30, 2013.

About Precision Optics Corporation
Precision Optics Corporation has been a leading developer and manufacturer of advanced optical instruments since 1982. Using proprietary optical technologies, the Company designs and produces next generation medical instruments, Microprecision™ micro-optics with characteristic dimensions less than 1 millimeter, and other advanced optical systems for a broad range of customers including some of the largest world-wide medical device companies. The Company's innovative medical instrumentation line includes state-of-the-art endoscopes and endocouplers as well as custom illumination and imaging products for use in minimally invasive surgical procedures. The Company believes that current advances in its proprietary micro-optics and 3D imaging technologies present significant opportunities for expanding applications to numerous potential medical products and procedures. The Company's website is www.poci.com. Investors can find Real-Time Quotes and market information for the Company on www.otcmarkets.com/stock/PEYE/quote.

About Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express the Company's intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company's future activities or future events or conditions. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performances and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those risks discussed in the Company's annual report on Form 10-K and in other documents that it files from time to time with the SEC. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this report, except as required by law.

PRECISION OPTICS CORPORATION
22 EAST BROADWAY
GARDNER, MASSACHUSETTS 01440-3338
Telephone 978 / 630-1800
Telefax 978 / 630-1487

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
Enterprise architects are increasingly adopting multi-cloud strategies as they seek to utilize existing data center assets, leverage the advantages of cloud computing and avoid cloud vendor lock-in. This requires a globally aware traffic management strategy that can monitor infrastructure health across data centers and end-user experience globally, while responding to control changes and system specification at the speed of today’s DevOps teams. In his session at 20th Cloud Expo, Josh Gray, Chie...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. Jack Norris reviews best practices to show how companies develop, deploy, and dynamically update these applications and how this data-first...
Intelligent Automation is now one of the key business imperatives for CIOs and CISOs impacting all areas of business today. In his session at 21st Cloud Expo, Brian Boeggeman, VP Alliances & Partnerships at Ayehu, will talk about how business value is created and delivered through intelligent automation to today’s enterprises. The open ecosystem platform approach toward Intelligent Automation that Ayehu delivers to the market is core to enabling the creation of the self-driving enterprise.
"At the keynote this morning we spoke about the value proposition of Nutanix, of having a DevOps culture and a mindset, and the business outcomes of achieving agility and scale, which everybody here is trying to accomplish," noted Mark Lavi, DevOps Solution Architect at Nutanix, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We're here to tell the world about our cloud-scale infrastructure that we have at Juniper combined with the world-class security that we put into the cloud," explained Lisa Guess, VP of Systems Engineering at Juniper Networks, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Historically, some banking activities such as trading have been relying heavily on analytics and cutting edge algorithmic tools. The coming of age of powerful data analytics solutions combined with the development of intelligent algorithms have created new opportunities for financial institutions. In his session at 20th Cloud Expo, Sebastien Meunier, Head of Digital for North America at Chappuis Halder & Co., discussed how these tools can be leveraged to develop a lasting competitive advantage ...
In his session at 20th Cloud Expo, Mike Johnston, an infrastructure engineer at Supergiant.io, discussed how to use Kubernetes to set up a SaaS infrastructure for your business. Mike Johnston is an infrastructure engineer at Supergiant.io with over 12 years of experience designing, deploying, and maintaining server and workstation infrastructure at all scales. He has experience with brick and mortar data centers as well as cloud providers like Digital Ocean, Amazon Web Services, and Rackspace. H...
The question before companies today is not whether to become intelligent, it’s a question of how and how fast. The key is to adopt and deploy an intelligent application strategy while simultaneously preparing to scale that intelligence. In her session at 21st Cloud Expo, Sangeeta Chakraborty, Chief Customer Officer at Ayasdi, will provide a tactical framework to become a truly intelligent enterprise, including how to identify the right applications for AI, how to build a Center of Excellence to ...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
SYS-CON Events announced today that Massive Networks will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Massive Networks mission is simple. To help your business operate seamlessly with fast, reliable, and secure internet and network solutions. Improve your customer's experience with outstanding connections to your cloud.
DevOps is under attack because developers don’t want to mess with infrastructure. They will happily own their code into production, but want to use platforms instead of raw automation. That’s changing the landscape that we understand as DevOps with both architecture concepts (CloudNative) and process redefinition (SRE). Rob Hirschfeld’s recent work in Kubernetes operations has led to the conclusion that containers and related platforms have changed the way we should be thinking about DevOps and...
As businesses adopt functionalities in cloud computing, it’s imperative that IT operations consistently ensure cloud systems work correctly – all of the time, and to their best capabilities. In his session at @BigDataExpo, Bernd Harzog, CEO and founder of OpsDataStore, presented an industry answer to the common question, “Are you running IT operations as efficiently and as cost effectively as you need to?” He then expounded on the industry issues he frequently came up against as an analyst, and ...
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
Given the popularity of the containers, further investment in the telco/cable industry is needed to transition existing VM-based solutions to containerized cloud native deployments. The networking architecture of the solution isolates the network traffic into different network planes (e.g., management, control, and media). This naturally makes support for multiple interfaces in container orchestration engines an indispensable requirement.
SYS-CON Events announced today that Datera, that offers a radically new data management architecture, has been named "Exhibitor" of SYS-CON's 21st International Cloud Expo ®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Datera is transforming the traditional datacenter model through modern cloud simplicity. The technology industry is at another major inflection point. The rise of mobile, the Internet of Things, data storage and Big...